Clinical Trial Update: Neoadjuvant Carboplatin and Vincristine and Standard Local Ophthalmic Therapy in Treating Patients With Intraocular Retinoblastoma [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating neoadjuvant carboplatin and vincristine with standard local ophthalmic therapy for intraocular retinoblastoma has completed with result…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Intraocular Retinoblastoma

Drugs mentioned

• CARBOPLATIN (Carboplatin)
• Vincristine (vincristine)

Snippet

Sponsor: Children's Oncology Group | Conditions: Intraocular Retinoblastoma | Phase 3 | Status: COMPLETED | Results posted: 2014-02-14